Community Cognitive Screening Using the Self-Administered Gerocognitive Examination (SAGE).
J Neuropsychiatry Clin Neurosci
; 26(4): 369-75, 2014.
Article
en En
| MEDLINE
| ID: mdl-24419587
ABSTRACT
This study investigated the functionality of the Self-Administered Gerocognitive Examination (SAGE) for cognitive screening in community settings and examined its characteristics as a cognitive screening assessment tool. From 45 community events, 1,047 individuals over age 50 were screened with SAGE. Cognitive impairment was identified in 28%. Principal-component and correlation analysis indicate that SAGE is an internally-consistent test that is very well balanced, with language, cognition, visuospatial, executive, and memory domains. Community cognitive screening using SAGE was found to be feasible and efficient in diverse settings with both small and large groups.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Características de la Residencia
/
Trastornos del Conocimiento
/
Pruebas Neuropsicológicas
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Límite:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Neuropsychiatry Clin Neurosci
Asunto de la revista:
NEUROLOGIA
/
PSIQUIATRIA
Año:
2014
Tipo del documento:
Article